This article has Open Peer Review reports available.
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
© The Author(s) 2017
Received: 7 June 2017
Accepted: 28 November 2017
Published: 28 December 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|7 Jun 2017||Submitted||Original manuscript|
|11 Aug 2017||Reviewed||Reviewer Report - Neelam Bhardwaj|
|13 Aug 2017||Reviewed||Reviewer Report - Kunle Odunsi|
|7 Sep 2017||Author responded||Author comments - Victor Jaravine|
|Resubmission - Version 2|
|7 Sep 2017||Submitted||Manuscript version 2|
|22 Nov 2017||Author responded||Author comments - Victor Jaravine|
|Resubmission - Version 3|
|22 Nov 2017||Submitted||Manuscript version 3|
|28 Nov 2017||Editorially accepted|
|28 Dec 2017||Article published||10.1186/s12885-017-3854-8|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.